Skip to contentLangermann Sol — NextCure, Inc. insider: 7 transactions · InsiderLensLangermann Sol
- Chief Scientific Officer at NextCure, Inc. · on record since May 8, 2019
Insider trading activity of Langermann Sol
- Transactions on record
- 7
- since Mar 3, 2020
- Open-market buys
- 0
- Open-market sells
- 0
- Companies traded
- 1
- last filing Feb 3, 2025
Figures computed from official regulatory filings — methodology.
Companies where Langermann Sol has traded
Track record of Langermann Sol
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of Langermann Sol
Co-insiders of Langermann Sol
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Guha UdayanNextCure, Inc.
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Feb 3, 2025 | AwardD | 117,375 | 0.00 USD | $0 | SEC |
| Apr 2, 2024 | AwardD | 93,900 | 0.00 USD | $0 | SEC |
| Feb 1, 2024 | AwardD | 117,375 | 0.00 USD | $0 | SEC |
| Mar 1, 2023 | AwardD | 135,000 | 0.00 USD | $0 | SEC |
| Feb 2, 2022 | AwardD | 117,400 | 0.00 USD | $0 | SEC |
| Mar 16, 2021 | AwardD | 100,000 | 0.00 USD | $0 | SEC |
| Mar 3, 2020 | AwardD | 78,200 | 0.00 USD | $0 | SEC |